~~<i id='08F04C02F6'><strike id='08F04C02F6'><tt id='08F04C02F6'><pre id='08F04C02F6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：fashion 2025-09-05 11:29:15 - browse：8661

The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： What to expect at HLTH 2023, the health care industry conference

leisure time

hotspot

leisure time

focus

Wikipedia

focus

MarkJ.Terrill/APAmidthestunningrebukeAmgensufferedatthehandsoftheU.S.FoodandDrugAdministrationthiswe

WSS

Stroke deaths set to near 10 million globally by 2050

AI can decode, harness the power of the humane immune system

The future of health care in the House

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Chemotherapy drug shortage eases slightly but still widespread

Dario to buy mental health app maker Twill in cash and stock deal

focus

entertainment

leisure time

At least 13 dead in Texas as scorching temps continue

He's a Nobel laureate. Critics say he was misleading on Covid

Duchenne breakthrough therapy leaves behind pioneering families

Bill would stop addiction treatment from triggering child abuse inquiry

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A new nitrogen execution bill also undermines medical licensing

Trump demands the U.S. pay no more for drugs than other countries … again

Senate panel eyes new effort on drug shortages

Alkermes shareholders re

Antivenom research: Lessons from HIV applied in search for universal antidote

hotspot

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

With competition flaring, obesity drug hits goal in liver disease study

Colorectal cancer study finds potential in overlooked immune cell

Why Charlie Gard's case is so disturbing to Americans

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

leisure time

focus

Wikipedia

focus